All-cause mortality and hospitalisation in univariate and multivariate analyses
| Variable | Univariate analysis | Multivariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value | |
| Age, per year | 1.02 | 0.98 to 1.05 | 0.25 | ||||||
| Male | 1.59 | 0.57 to 4.4 | 0.37 | ||||||
| Systolic BP, per 1 mm Hg | 0.97 | 0.95 to 0.99 | 0.008 | 0.976 | 0.95 to 0.99 | 0.02 | |||
| Systolic BP, per 10 mm Hg | 0.74 | 0.60 to 0.92 | 0.008 | 0.77 | 0.63 to 0.96 | 0.02 | |||
| Diastolic BP, per 1 mm Hg | 0.97 | 0.95 to 0.99 | 0.01 | ||||||
| Diastolic BP, per 10 mm Hg | 0.76 | 0.61 to 0.95 | 0.02 | ||||||
| Heart rate, per 1 bpm | 0.98 | 0.96 to 0.99 | 0.04 | ||||||
| Heart rate, per 10 bpm | 0.83 | 0.69 to 1.003 | 0.053 | ||||||
| BNP, pg/mL | 1.0 | 1.001 to 1.004 | <0.001 | 1.003 | 1.001 to 1.004 | 0.001 | |||
| BNP, per 50 pg/mL | 1.13 | 1.063 to 1.202 | <0.001 | 1.14 | 1.06 to 1.24 | 0.001 | |||
| hs-CRP at stable state, mg/dL | 1.39 | 0.99 to 1.95 | 0.06 | ||||||
| hs-CRP >0.3 mg/dL at stable state | 4.01 | 1.45 to 11.1 | 0.007 | ||||||
| LGE present | 3.74 | 1.35 to 10.3 | 0.01 | ||||||
| LGE present, CRP> 0.3 mg/dL | 4.04 | 1.67 to 9.76 | 0.002 | 2.913 | 1.19 to 7.15 | 0.02 | 3 | 1.22 to 7.38 | 0.02 |
| LV EF, per 1% | 1.02 | 0.98 to 1.06 | 0.39 | ||||||
| LV EDV, per 1 mL/m2 | 1.001 | 0.99 to 1.0 | 0.58 | ||||||
| LV ESV, per 1 mL/m2 | 1.001 | 0.99 to 1.01 | 0.83 | ||||||
| LV SV, per 1 mL | 1 | 0.99 to 1.003 | 0.95 | ||||||
| LV mass, per g/m2 | 0.99 | 0.98 to 1.005 | 0.46 | ||||||
BNP, B-type natriuretic peptide; BP, blood pressure; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; hs-CRP, high-sensitivity C reactive protein; LBBB, left bundle branch block; LGE, late gadolinium-enhancement; LV, left ventricular; SV, stroke volume.